Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

Explore clinical trials studying Philadelphia Chromosome-Positive Chronic Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Philadelphia Chromosome-Positive Chronic Myeloid Leukemia trial results

Active, Not Recruiting

A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)

NCT05456191

Conditions: Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations: Rocky Mountain Cancer Centers Denver, Colorado, United States

Illinois Cancer Care Peoria, Illinois, United States

Regions Hospital Saint Paul, Minnesota, United States

Messino Cancer Centers Asheville, North Carolina, United States

View all 120 locations

View Trial Details

Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

Philadelphia Chromosome-Positive Chronic Myeloid Leukemia trial results

A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)

Related conditions